Find a Trial

Trial Summary


Protocol No.CTO-GOG-3053
StatusOPEN TO ACCRUAL
Principal InvestigatorLandrum, Lisa
ScopeNational
PhasePhase III
Age GroupAdult
TitleA Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053).
Applicable Disease SitesOther Female Genital
Participating InstitutionsIU Health North Hospital
    Indiana University (IU)
      Treatment TypeTreatment
      ContactPhone: (317) 278-5632
      Email: iutrials@iu.edu